Genetic ‘chips’ to help identify genes, molecules behind CAD
June 14th, 2010 - 6:29 pm ICT by IANSLondon, June 14 (IANS) In an attempt to identify new genes and molecules responsible for coronary artery disease (CAD), researchers will use state-of-the-art genetic techniques to examine DNA from over 20,000 heart patients.
CAD is a condition in which plaque (a compound of fat, cholesterol and other substances found in the blood) builds up inside the coronary arteries.
The study, which may help develop new diagnostic and treatment strategies, is being undertaken by postgraduate researcher Paraskevi Christofidou of the Department of Cardiovascular Sciences at the University of Leicester (UL).
Christofidou said: “Coronary Artery Disease - a disease causing narrowing of arteries in the heart - remains a major cause of death worldwide. Shockingly, in the USA on average one person dies of this disease every 34 seconds.”
In the UK, it causes over 100,000 deaths a year, approximately one in five deaths in men and one in six deaths in women.
“Various risk factors such as high blood pressure, smoking, obesity and increased levels of cholesterol play a significant role in the progression of CAD,” Christofidou said.
“There is also evidence that familial predisposition is a strong risk factor. Risk of CAD increases by almost 50 percent if one of your relatives has a history of heart disease,” added Christofidou.
Christofidou said a part of this genetic susceptibility to CAD is transmitted from one generation to another as a collection of small changes in DNA sequence called single nucleotide polymorphisms (SNPs).
She added: “The recent genetic revolution offers tracking of SNPs in human DNA on an unprecedented scale. With the use of new genetic tools called ‘chips’ it is possible to track and characterise precisely up to 1 million SNPs in a subject.”
“We anticipate that some of these variants occur more frequently in patients with CAD compared to healthy subjects and are responsible for genetic predisposition to CAD. It is likely that some of these variants are rare so large cohorts of subjects are needed to identify sufficient numbers for analysis,” Christofidou said.
The project will conduct analysis of human DNA from more than 20,000 patients with CAD and 60,000 healthy controls, said a UL release.
Christofidou will present her research at the Festival of Postgraduate Research June 24 at UL.
- How genetic 'chips' could improve heart disease treatments - Jun 25, 2010
- Heart disease likely to pass from father to son - Feb 09, 2012
- Scientists find 13 new genes linked to heart diseases - Mar 07, 2011
- Heart disease may be linked to prostate cancer - Feb 09, 2012
- Non-invasive respiratory stress test to detect significant coronary artery disease - May 14, 2010
- 13 genes behind heart disease uncovered - Mar 07, 2011
- Scientists isolate genes behind BP, stroke, cardiac risks - Sep 12, 2011
- World's first bedside genetic test developed - Mar 30, 2012
- Alcohol ups risk of coronary artery disease in Chinese men - Dec 10, 2010
- Bits of molecular "trash" in blood may be good indicators of heart disease - Feb 20, 2010
- Severe angina linked to greater heart risk in women - Jul 09, 2010
- Routine periodic fasting good for health, heart - Apr 04, 2011
- Molecular debris can predict cardiovascular risks - Feb 20, 2010
- Ultrasound technique better alternative to invasive angiography for diagnosing heart disease - Jun 15, 2010
- High calcium level in arteries predicts heart attack - Jul 28, 2009
Tags: cardiovascular sciences, coronary arteries, coronary artery disease, dna sequence, familial predisposition, genetic predisposition, genetic revolution, genetic susceptibility, genetic techniques, genetic tools, heart patients, high blood pressure, history of heart disease, human dna, nucleotide polymorphisms, postgraduate researcher, risk factor, snps, treatment strategies, unprecedented scale